| # | Drug | Count |
|---|---|---|
| 0 | CYTARABINE | 388 |
| 1 | CYCLOPHOSPHAMIDE | 344 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 344 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 344 |
| 4 | ETOPOSIDE | 269 |
| 5 | DEXAMETHASONE | 252 |
| 6 | DEXAMETHASONE 1.5 MG | 252 |
| 7 | METHOTREXATE SODIUM | 234 |
| 8 | DOXORUBICIN | 220 |
| 9 | METHOTREXATE | 205 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM DIHYDROGEN PHOSPHATE | 1 | 0.0345 |
| 1 | SEROTONIN | 8 | 0.0294 |
| 2 | ISOTONIC SODIUM CHLORIDE | 2 | 0.0267 |
| 3 | URIDINE TRIACETATE | 3 | 0.0201 |
| 4 | PALIFERMIN | 6 | 0.0154 |
| 5 | SACITUZUMAB GOVITECAN | 59 | 0.0122 |
| 6 | FLOXURIDINE | 2 | 0.0116 |
| 7 | IDARUBICIN HYDROCHLORIDE | 13 | 0.0112 |
| 8 | FOSNETUPITANT AND PALONOSETRON | 11 | 0.0092 |
| 9 | NETUPITANT AND PALONOSETRON | 11 | 0.0092 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 708 |
| 1 | Corticosteroid [EPC] | 517 |
| 2 | Platinum-based Drug [EPC] | 460 |
| 3 | Alkylating Drug [EPC] | 455 |
| 4 | Topoisomerase Inhibitor [EPC] | 272 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 251 |
| 6 | Microtubule Inhibitor [EPC] | 235 |
| 7 | Leukocyte Growth Factor [EPC] | 199 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 153 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 138 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 6 | 0.0154 |
| 1 | CD33-directed Immunoconjugate [EPC] | 29 | 0.0079 |
| 2 | Anthracycline Topoisomerase Inhibitor [EPC] | 16 | 0.0066 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 57 | 0.0065 |
| 4 | Lymphocyte Growth Factor [EPC] | 6 | 0.0048 |
| 5 | Nucleoside Analog Antifungal [EPC] | 6 | 0.0042 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 21 | 0.0036 |
| 7 | Asparagine-specific Enzyme [EPC] | 48 | 0.0036 |
| 8 | Topoisomerase Inhibitor [EPC] | 272 | 0.0035 |
| 9 | Echinocandin Antifungal [EPC] | 23 | 0.0028 |